Skip to content
Screener

Guardant Health GH Total costs & expenses

Total costs & expenses at other companies

Veracyte logo
VeracyteVCYT
$78.51M+2.5%
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
$90.08M+9.8%
Personalis, Inc. logo
Personalis, Inc.PSNL
$47.63M+24.4%
GRAIL, Inc. logo
GRAIL, Inc.GRAL
$176.55M-4.8%
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
$458.4M+21.8%
Natera, Inc. logo
Natera, Inc.NTRA

Other financials

Income statement

See full
Revenue$301.7M+48.3%
Gross profit$196.7M+52.8%
Operating income-$121.4M-9.3%
Net income-$112.1M-17.8%
EPS (diluted)-$0.85-10.4%

Balance sheet

See full
Cash & equivalents$1.1B+37.0%
Total debt$1.7B+30.5%
Total equity-$181.1M+27.8%
Total assets$1.9B+42.5%

Cash flow

See full
Operating cash flow-$65.6M-4.7%
CapEx$5.6M+25.1%
Free cash flow-$71.2M-6.0%

Valuation

See full
Market cap$21.74B+294%
Enterprise value$22.34B+266%
P/S20.1×+13.5×

Profitability

See full
Gross margin64.9%+3.6pp
Operating margin-41.4%-9.4pp
Net margin-40.1%-8.1pp
FCF margin-22%-6.7pp

Returns & leverage

See full
Return on equity-438.1%-1,655pp
Debt / equity
Current ratio4.7×+0.6×

Where this comes from

Reported directly by Guardant Health in its filing.

Tagged under the XBRL concept us-gaap:CostsAndExpenses.

The source filing: Guardant Health’s 10-Q, filed May 7, 2026. Open the filing →

Filed
May 7, 2026, 5:16 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001576280-26-000026

FAQ

What is Guardant Health's total costs & expenses?
Guardant Health (GH) reported total costs & expenses of $423.02M in Q1 2026.
How has Guardant Health's total costs & expenses changed year-over-year?
Guardant Health's total costs & expenses increased by 34.5% year-over-year, from $314.51M to $423.02M.
What is the long-term trend for Guardant Health's total costs & expenses?
Over 4 years (2021 to 2025), Guardant Health's total costs & expenses has grown at a 16.0% compound annual growth rate (CAGR), from $784.65M to $1.42B.
What does total costs & expenses mean?
This metric represents the aggregate sum of all operating and non-operating costs incurred by the company to support its business activities, including cost of revenue, research and development, and selling, general, and administrative expenses. It serves as a comprehensive measure of the total capital outflow required to sustain operations and drive product development. Monitoring this figure allows investors to evaluate the company's overall cost structure and its ability to manage expenditures relative to revenue growth.

Ask your AI about Guardant Health's total costs & expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude